Overview

Stromal Vascular Fraction Market is predicted to register a CAGR of over 4.1% during the forecast period 2020 to 2027.

Stromal vascular fraction is crucial in regenerative medicine and in treating various chronic disorders. Multiple clinical and pre-clinical investigations have been undertaken for establishing the function of stromal vascular fraction for treating osteoarthritis, rheumatoid arthritis, cartilage regeneration, etc. This method has huge potential in treating orthopaedics due to their homeostatic and immune-modulation properties. Furthermore, the regenerative abilities of SVT are derivations of soluble factors having multiple differentiating abilities with huge potential. Moreover, the SVF injections are intrusive and non-surgical option in orthopaedics for treating musculoskeletal diseases. Such factors shall positively impact the stromal vascular fraction market growth.

Stromal Vascular Fraction Market Segmentation:

By Product
• SVF Aspiration Products
• SVF Transfer Products
• SVF Isolation Products

By Application
• Cosmetic Applications
• Orthopedic Applications
• Soft Tissue Applications
• Others

By End User
• Hospitals
• Specialty Clinics
• Stem Cell Banks/ Laboratories
• Others

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

The market is categorised into product, application, end user and region. The product segment is classified into SVF aspiration products, SCF transfer products, SVF isolation products. The SVF isolation products segment is further divided into enzymatic isolation products, non-enzymatic isolation products, automated POC devices. The application segment is fragmented into cosmetic applications, orthopedic applications, soft tissue applications and others. The end user segment is diversified into hospitals, specialty clinics, stem cell banks and others.

Regional Analysis:
The North America region is expected to hold the largest stromal vascular fraction market share owing to the rising prevalence of musculoskeletal disorders like osteoarthritis, growing awareness pertaining to stem cell therapy, soaring number of cosmetic surgeries along with growing insistence from clinicians. Furthermore, the increasing investments in research and development of novel technologies coupled with the escalating number of private hospitals across the region.

Competitive Landscape:                            
The key market players included are IntelliCell BioSciences Inc., Cytori Therapeutics Inc., Cellular Biomedicine Group Inc., InGeneron Inc., Lifecell Corporation (Allergen PLC), GE Healthcare (Biosafe Group SA), Tissue Genesis Inc.

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global stromal vascular fraction market by product, by application, by field end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
     1.1 Objectives of the Study
     1.2 Market Definition
     1.3 Market Scope
        1.3.1 Years Considered for the Study
        1.3.2 Market Covered
     1.4 Currency
     1.5 Limitations
     1.6 Stakeholders
2. Research Methodology
      2.1 Research Data
         2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
          2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
      2.2 Market Size Estimation
      2.3 Market Breakdown and Data Triangulation
              2.4 Assumptions for the Study  
3. Executive Summary
      3.1 Market Outlook
      3.2 Segment Outlook
      3.3 Competitive Insights
4. Market Variables, Trends & Scope
      4.1 Market Lineage Outlook
      4.2 Penetration and Growth Prospect Mapping
      4.3 Industry Value Chain Analysis
      4.4 Cost Analysis Breakdown
      4.5 Technology Overview
      4.6 Regulatory Framework on Country Level
             4.6.1 Reimbursement Framework
             4.6.2 Standards and Compliances
5. Market Overview
     5.1 Market Dynamics
        5.1.1 Market Driver Analysis
        5.1.2 Market Restraint Analysis
        5.1.3 Industry Challenges       
6. Market Analysis tools
       6.1 Industry Analysis - Porter’s
            6.1.1 Supplier Power
            6.1.2 Buyer Power
            6.1.3 Substitution Threat
            6.1.4 Threat from new entrants
            6.1.5 Competitive Rivalry
        6.2 Pestel Analysis
            6.2.1 Political Landscape
            6.2.2 Environmental Landscape
            6.2.3 Social landscape
            6.2.4 Technology landscape
            6.2.5 Legal Landscape
7. Stromal Vascular Fraction Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
       7.1 High Field Stromal Vascular Fraction
       7.2 Low to Mid Field Stromal Vascular Fraction
       7.3 Very High Field Stromal Vascular Fraction
8. Stromal Vascular Fraction Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
        8.1 Cosmetic Applications
        8.2 Orthopedic Applications
        8.3 Soft Tissue Applications
        8.4 Others
9. Stromal Vascular Fraction Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
        9.1 Hospitals
        9.2 Specialty Clinics
        9.3 Stem Cell Banks/ Laboratories
        9.4 Others
10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
                 10.2.1. U.S.
                 10.2.2. Canada
                 10.2.3. Mexico
                 10.2.4 Rest of North America
    10.3 Market Size (USD Mn) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    11.1. Introduction
    11.2. Regional Market Trends
    11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
               11.3.1. Brazil
               11.3.2. Uruguay
               11.3.3 Argentina
               11.3.4. Rest of Latin America
    11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
                12.2.1. Germany
                12.2.2. U.K
                12.2.3. France
                12.2.4. Italy
                12.2.5 Switzerland
                12.2.6. Spain
                12.2.7. Russia
                12.2.8. Poland
                12.2.9. Rest of Western Europe
               12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
      13.1 Introduction
      13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
        13.2.1 Japan
        13.2.2 China
        13.2.3 Singapore
        13.2.4 Korea        
        13.2.5 India
        13.2.6 Australia and New Zealand
        13.2.7 ASEAN
        13.2.8 Rest of Asia Pacific
    13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
      14.1 Introduction
      14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019
             14.2.1 UAE
             14.2.2 South Africa
             14.2.3 Egypt
             14.2.4 Saudi Arabia
             14.2.5 Rest of MEA
      14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
15.1 IntelliCell BioSciences Inc.
   15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.1.2. Product Portfolio
   15.1.3. SWOT Analysis
   15.1.4. Financial Overview
   15.1.5. Strategic Overview
15.2 Cytori Therapeutics Inc.
   15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.2.2. Product Portfolio
   15.2.3. SWOT Analysis
   15.2.4. Financial Overview
   15.2.5. Strategic Overview
15.3 Cellular Biomedicine Group Inc.
   15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.3.2. Product Portfolio
   15.3.3. SWOT Analysis
   15.3.4. Financial Overview
   15.3.5. Strategic Overview
15.4 InGeneron Inc.
   15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.4.2. Product Portfolio
   15.4.3. SWOT Analysis
   15.4.4. Financial Overview
   15.4.5. Strategic Overview
15.5 Lifecell Corporation (Allergen PLC)
   15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.5.2. Product Portfolio
   15.5.3. SWOT Analysis
   15.5.4. Financial Overview
   15.5.5. Strategic Overview
15.6 GE Healthcare (Biosafe Group SA)
   15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.6.2. Product Portfolio
   15.6.3. SWOT Analysis
   15.6.4. Financial Overview
   15.6.5. Strategic Overview
15.7 Tissue Genesis Inc.
   15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
   15.7.2. Product Portfolio
   15.7.3. SWOT Analysis
   15.7.4. Financial Overview
   15.7.5. Strategic Overview
16 Impact of COVID-19
   16.1. Positive influence on the healthcare industry
   16.2. The financial disruption of the manufacturing sector
   16.3. Impact of COVID-19 on emerging companies
   16.4. Significant mandates in the healthcare regulations initiated by administrations
   16.5. The overall economic slowdown of the developing and developed nations
17 Competitive Intelligence and Competitive Matrix
   17.1 Competitive Intelligence
   17.2 Competitive Matrix
18. Major Deals and Strategic Alliances Analysis
   18.1 Joint ventures
   18.2 Mergers and acquisitions
   18.3 Licensing and partnerships
   18.4 Technology Collaborations
   18.5 Strategic Divestments
   18.6 Market Entry Strategies        
19. Relevant Case Studies and Latest News Updates
20. Key Market Takeaway Points from the Market Analysts at FutureWise Market Research

Tables

Figures